MDA-MB-361

92020423, human breast (brain metastasis), Epithelial

• UNSPSC-Code: 41106514
• eCl@ss: 32190102

Eigenschaften

• product name: MDA-MB-361, 92020423
• Biologische Quelle: human breast (brain metastasis)
• Wachstumsmodus: Adherent
• Karyotyp: Modal no. 56
• Morphologie: Epithelial
• Produkte: Not specified
• Rezeptoren: Not specified
• Methode(n): cell culture | mammalian: suitable
• Relevante Krankheit(en): metastasis
• Versandbedingung: dry ice
• Lagertemp.: −196°C

Beschreibung

Ursprung der Zelllinie

Human Caucasian breast adenocarcinoma

Beschreibung der Zelllinie

This cell line originates from a 40 year old caucasian female suffering from a breast adenocarcinoma but these cells were isolated from a metastatic site in the brain.

Anwendung

MDA-MB-361 has been used to study the effects of low-intensity cytotoxic ultrasound irradiation for induction of cell ablation.

Nährmedium

L15 + 2mM Glutamine + 15% Foetal Bovine Serum (FBS).

Subkultur-Routine

Split sub-confluent cultures (70-80%) 1:3 to 1:6, i.e. seeding at 3-6x10,000 cells/cm² using 0.05% trypsin or trypsin/EDTA; 37°C. CO₂ is not required.

Sonstige Hinweise

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.

Haftungsausschluss

This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form.